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SObjective: Laparoscopic repair of giant paraesophageal hernia is a complex operation requiring significant
laparoscopic expertise. Our objective was to compare our current approach and outcomes for laparoscopic repair
of giant paraesophageal hernia with our previous experience.
Methods: A retrospective review of patients undergoing nonemergency laparoscopic repair of giant paraesopha-
geal hernia, stratified by early versus current era (January 1997–June 2003 and July 2003–June 2008), was
performed. We evaluated clinical outcomes, barium esophagogram, and quality of life.
Results: Laparoscopic repair of giant paraesophageal hernia was performed in 662 patients (median age 70 years,
range 19–92 years) with a median percentage of herniated stomach of 70% (range 30%–100%). With time, use
of Collis gastroplasty decreased (86% to 53%), as did crural mesh reinforcement (17% to 12%). Current era
patients were 50% more likely to have a Charlson comorbidity index score greater than 3. Thirty-day mortality
was 1.7% (11/662). Mortality and complication rates were stable with time, despite increasing comorbid disease
in current era. Postoperative gastroesophageal reflux disease health-related quality of life scores were available for
489 patients (30-month median follow-up), with good to excellent results in 90% (438/489). Radiographic recur-
rence (15.7%) was not associated with symptom recurrence. Reoperation occurred in 3.2% (21/662).
Conclusions:With time, we have obtained significant minimally invasive experience and refined our approach to
laparoscopic repair of giant paraesophageal hernia. Perioperative morbidity and mortality remain low, despite
increased comorbid disease in the current era. Laparoscopic repair provided excellent patient satisfaction and
symptom improvement, even with small radiographic recurrences. Reoperation rates were comparable to the
best open series. (J Thorac Cardiovasc Surg 2010;139:395-404)Supplemental material is available online.
Surgical repair of giant paraesophageal hernia (GPEH) is
a complex operation, and the laparoscopic approach requires
advanced laparoscopic expertise. With time, the feasibility
and safety of a laparoscopic approach to GPEH repair
have been established1-3; however, there is still considerable
debate regarding the optimal approach to operative repair,
use of routine mesh reinforcement of the hiatus, the need
for an esophageal lengthening procedure, and routine fundo-
plication. Attempts to address these questions have been
limited by the small numbers of patients reported in most
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The Journal of Thoracic and CaDuring the past decade, we have refined the operation and
acquired significant experience in advanced laparoscopic
techniques. This study was designed to achieve the follow-
ing aims: (1) to describe the perioperative morbidity and
mortality associated with the laparoscopic approach and to
determine whether these rates have changed during the
period of study; (2) to evaluate patient and operative factors
contributing to increased risk of perioperative adverse
outcomes; (3) to assess symptom relief, quality of life, radio-
graphic and symptomatic recurrence, and the need for reop-
eration for symptomatic recurrent hernia during follow-up;
and (4) to identify potential risk factors for radiographic
recurrence and the need for reoperation.MATERIALS AND METHODS
Patient Selection and Stratification
Patients undergoing elective or urgent laparoscopic repair of GPEH
(defined as>30% of the stomach herniated into the mediastinum) from
January 1, 1997, to June 30, 2008, were included. During this period, 739
consecutive patients underwent operative repair of GPEH. For this analysis,
patients were excluded if they required emergency surgery (n ¼ 13), had
a planned open operation (n ¼ 13), or had previous antireflux surgery
(n¼ 51). Patients requiring hospitalization for hernia-associated symptoms
and repaired urgently during the same admission were included in this anal-
ysis (n ¼ 106, 16%). This retrospective study was approved by our institu-
tional review board.rdiovascular Surgery c Volume 139, Number 2 395
Abbreviations and Acronyms
BMI ¼ body mass index
CCI ¼ Charlson comorbidity index
CI ¼ confidence interval
GERD-HRQoL ¼ Gastroesophageal Reflux
Disease Health Related
Quality of Life
GPEH ¼ giant paraesophageal hernia
IQR ¼ interquartile range
LOS ¼ length of stay
OR ¼ odds ratio
SF-36 ¼ Medical Outcomes Study Short
Form-36 Health Survey
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SPatient Demographic Characteristics and Operative
Techniques
Attempted elective or urgent laparoscopic repair of GPEH was
performed in 662 consecutive patients. Conversion to an open procedure
was necessary in 10 cases (1.5%) for bleeding (n ¼ 3), gastric perforation
or serosal tear (n ¼ 2), adhesions (n ¼ 3), or inability to reduce the hernia
laparoscopically (n ¼ 2). Most patients were female (75%, median age
70 years, interquartile range [IQR] 19–92 years). Body mass index (BMI)
of at least 35 kg/m2 was documented in 15% of patients. Preoperative his-
tory of anemia or hematocrit lower than 37% was found in 41% of patients
(n ¼ 271/654). Age-adjusted Charlson comorbidity index (CCI) score was
at least 3 for 49% of patients.
Operative Approach
The operative approach to laparoscopic GPEH repair continues to be
a work in progress (details online in Appendix E1.) In this series, esophageal
lengthening (Collis gastroplasty) was used in 63%, mesh cruroplasty in
13%, and fundoplication (floppy Nissen or partial fundoplasty) in 98%
(Table 1). Operationswere performed by 13 thoracic surgeons at the Univer-
sity of Pittsburgh Medical Center. Two senior surgeons, J.D.L. and R.J.L.,
performed 56% (n ¼ 372) and 17% (n ¼ 114), respectively. Under senior
supervision, junior surgeons with advanced minimally invasive foregut
surgical training (minimum of 25 laparoscopic GPEH repairs) performed
the remaining operations. Independent operation required a minimum of
10 successful proctored cases.Database
With a standardized outcome protocol, data on patients undergoing
repair of GPEHwere collected retrospectively by trained research personnel
and entered into a computerized surgical outcomes database. Data included
standard observer-recorded measures, preoperative symptoms, laboratory
and radiographic studies, operative details, length of stay (LOS), perioper-
ative mortality, and postoperative adverse outcomes (in-hospital and 30-day
outcomes).
Symptom assessment questionnaire, barium esophagogram, the Gastro-
esophageal Reflux Disease Health Related Quality of Life (GERD-HRQoL)
instrument,4,5 and the Medical Outcomes Study Short Form-36 Health Sur-
vey (SF-36)6 were obtained as described previously.7 The GERD-HRQoL
and SF-36 questionnaires were administered in the clinic by trained clinic
personnel. Raw GERD-HRQoL scores were converted to categoric vari-
ables as follows: excellent for 0 to 5, good for 6 to 10, fair for 11 to 15,
and poor for 16 or greater.8 Radiographic recurrence was considered present
if more than 10% or 2 cm of the stomach was located above the level of the396 The Journal of Thoracic and Cardiovascular Surgdiaphragm on barium esophagraphy.7,9 All subsequent esophageal opera-
tions were recorded, including reoperation for recurrence (n ¼ 21), conver-
sion to Roux-en-Y procedure for obesity (n ¼ 3), and esophagectomy for
cancer (n ¼ 3).
Statistical Analysis
Statistical analysis was performed with STATA SE 10.0 software
(StataCorp LP, College Station, Tex). Primary outcome variables were
as follows: (1) perioperative mortality (in-hospital or 30-day mortality)
and (2) major morbidity (including pneumonia, perioperative hernia
recurrence, postoperative leak, pulmonary embolism, need for reopera-
tion, and hospital readmission) and LOS. Secondary outcome measures
were as follows: (1) reoperation for recurrent hernia, (2) radiographic
recurrence according to barium esophagography, and (3) patient-reported
outcomes.
Perioperative Morbidity and Mortality Associated
With Laparoscopic Approach
Data were summarized with frequencies and percentages for categoric
variables and median with IQR for continuous variables for the entire cohort
and then stratified by date of surgery (early January 1, 1997–June 30, 2003,
current July 1, 2003–June 30, 2008). Fisher’s Exact Test, c2 test, and Stu-
dent t test, accounting for unequal variance, were used to describe differ-
ences between groups. To determine factors associated with increased
risk for death or major adverse outcomes, crude and adjusted analyses
were performed with univariate and multivariate logistic regression. Preop-
erative and current (most recent) patient-reported outcomes measures were
compared with the McNemar c2 test for differences in proportions of paired
outcomes. With logistic regression, the odds ratios (ORs) for radiographic
recurrence, reoperation for recurrence, and recurrent symptoms associated
with the finding of recurrent hiatal hernia on barium esophagography
were determined. Two-sample Wilcoxon rank-sum (Mann–Whitney) test
for differences between means was used to calculate the differences in
SF-36 summary scores and GERD-HRQoL composite score, stratified by
radiographic hernia recurrence.
Missing Data
When clear documentation of the presence or absence of a symptom was
not found in retrospective chart review, the data were considered missing.
Recognizing that missing data may introduce bias into the analysis, patient
factors associated with the probability of data being missing were evaluated
with Fisher’s Exact Test and univariate logistic regression.RESULTS
Perioperative Morbidity and Mortality After
Laparoscopic GPEH Repair
Major adverse outcomes included pneumonia (n ¼ 29/
653, 4%), congestive heart failure (n ¼ 17/654, 2.6%),
pulmonary embolism (n ¼ 22/653, 3.4%), postoperative
leak (n ¼ 16/653, 2.5%), perioperative hernia recurrence
(n ¼ 5/652, 0.8%), need for reintubation (n ¼ 17/655,
2.6%), acute renal failure (n ¼ 6/656, 0.9%), cerebrovas-
cular accident (n ¼ 4/653, 0.6%), and myocardial infarc-
tion (n ¼ 6/653, 0.9%). Most postoperative leaks
occurred in patients who underwent Collis gastroplasty
(n ¼ 14/16, 88%). There were 11 postoperative deaths
(n ¼ 11/662, 1.7%). Reoperation within 30 days was
performed in 32 cases (n ¼ 32/650, 4.9%) for postopera-
tive leak (n ¼ 11), recurrent hernia (n ¼ 3), visceral injuryery c February 2010
TABLE 1. Cohort analysis of early (January 1, 1997–June 30, 2003) versus current (July 1, 2003–June 30, 2008) surgical experience
Overall (n ¼ 662) Early (n ¼ 202) Current (n ¼ 460) Crude odds ratio* P value
Patient demographic data
Male 167 (25%) 57 (28%) 110 (24%) 0.8 (0.5–1.2) .24
Age 70 y 336 (51%) 101 (50%) 235 (51%) 1.0 (0.8–1.5)y .8
Obese (body mass index 35 kg/m2, n ¼ 620) 92 (15%) 25 (13%) 67 (15%) 1.2 (0.7–1.9) .6
Charlson comorbidity index 3y (n ¼ 660) 326 (49%) 85 (42%) 241 (53%) 1.5 (1.1–2.1) .01
Preoperative hernia size (%)z
30%–49% 280 (42%) 78 (39%) 202 (44%) Referent .12
50%–74% 87 (13%) 23 (11%) 64 (14%) 1.1 (0.6–1.9)
75%–99% 148 (22%) 52 (26%) 96 (21%) 0.7 (0.5–1.1)
Intrathoracic stomach 147 (22%) 49 (24%) 98 (21%) 0.8 (0.5–1.2)
Preoperative pulmonary disease 163 (25%) 38 (19%) 125 (27%) 1.6 (1.1–2.4) .02
History of ever smoking (n ¼ 650) 251 (39%) 70 (36%) 181 (40%) 1.2 (0.8–1.7) .32
Preoperative symptoms
Chest or abdominal pain (n ¼ 655) 353 (54%) 102 (51%) 251 (55%) 1.2 (0.8–1.7) .33
Heartburn (n ¼ 650) 431 (66%) 118 (59%) 313 (70%) 1.6 (1.1–2.3) .007
Dysphagia (n ¼ 648) 280 (43%) 76 (38%) 204 (45%) 1.3 (0.96–1.9) .09
Difficulty swallowing (n ¼ 637)
Hard solids 204 (32%) 54 (28%) 150 (34%) 1.4 (0.9–2.0)x .29
Soft solids 42 (7%) 10 (5%) 32 (7%) 1.6 (0.8–3.4)x
Liquids 21 (3%) 8 (4%) 13 (3%) 0.8 (0.3–2.0)
Regurgitation (n ¼ 655) 388 (59%) 110 (55%) 278 (61%) 1.3 (0.9–1.8) .12
Dyspnea (n ¼ 650) 273 (42%) 72 (36%) 201 (45%) 1.4 (1.0–2.0) .03
Bloating (n ¼ 634) 195 (31%) 57 (29%) 138 (32%) 1.2 (0.8–1.7) .4
Operative details
Esophageal lengthening procedure (n ¼ 647) 408 (63%) 171 (86%) 237 (53%) 0.2 (0.1–0.3) <.0001
Fundoplication 647 (98%) 198 (98%) 449 (98%) 0.8 (0.3–2.6) .74
Mesh reinforcement of crura 88 (13%) 35 (17%) 53 (12%) 0.6 (0.4–0.99) .04
Conversion to open operation 10 (1.5%) 2 (1%) 8 (1.7%) 1.8 (0.4–8.4) .47
Operative time>260 minx (n ¼ 630) 182 (29%) 85 (42%) 97 (21%) 0.4 (0.3–0.5) <.0001
Data are presented as numbers of patients with percentages in parentheses. *Odds ratio represents the odds of each variable in the current cohort compared to the early cohort; 95%
confidence interval is given in parentheses. yCharlson comorbidity index adjusted for age. zPercentage of stomach within the mediastinum determined by barium esophagography,
preoperative endoscopy, or intraoperative description. Complete intrathoracic stomach was defined as the entire stomach, including the antrum, herniated into the mediastinum.
xOperative time longer than 260 minutes represents the 75th percentile for operative time for the entire cohort.
Luketich et al General Thoracic Surgery
G
T
S(n ¼ 2), wound infection requiring incision and drainage (n
¼ 2), bleeding (n ¼ 2), enteral access for nutrition (n ¼ 6),
obstructing fundoplication (n ¼ 1), small-bowel obstruc-
tion (n ¼ 1), empyema (n ¼ 1), retained foreign body
(n ¼ 1), paraesophageal hematoma (n ¼ 1), and incisional
hernia (n ¼ 1).Laparoscopic Repair of GPEH in the Current Era
During the study period, significant shifts in the patient
cohort undergoing nonemergency laparoscopic repair, the
approach to operation, and operative details have occurred
(Table 1). Adverse outcomes in the postoperative period
did not differ significantly between the eras, despite the in-
creased comorbid disease burden in the current cohort
(data not shown). Current era patients were 60% less likely
to undergo reoperation in the immediate postoperative
period (OR, 0.4; 95% confidence interval [CI], 0.2–0.9)
but were 2.3 times more likely to require admission to the in-
tensive care unit than in the early era (OR, 2.3; 95% CI,The Journal of Thoracic and Ca1.5–3.4). This finding reflects the increased prevalence of
comorbid diseases in the current patient population. Median
postoperative LOS was 3 days (IQR, 2–5 days) and did not
differ significantly between the eras (early era LOS, 3 days;
IQR, 2–5 days, vs current era LOS, 4 days; IQR, 2–5 days;
P ¼ .62). The 7.5% need for hospital readmission after
discharge (n ¼ 15/201) in the early era was similar to 8%
(37/458) in the current era (P ¼ .9), and postoperative mor-
talities were similar between the eras (n ¼ 2/202, 1%, vs
n ¼ 9/460, 2%, P ¼ .52). The most common reason for
readmission was thromboembolic complication (n ¼ 6/52,
11.5%).Factors That May Contribute to Increased Odds of
Adverse Outcome
Postoperative mortality. All postoperative deaths were of
patients with 1 or more of the following characteristics: age
of at least 70 years, BMI of at least 35 kg/m2, and age-ad-
justed CCI of at least 3. Mortality at 30 days increasedrdiovascular Surgery c Volume 139, Number 2 397
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years, 0.9% for ages 70–79 years, 7.8% for ages80 years,
P< .001). Postoperative mortality was also associated with
urgency of operation. Patients admitted electively for opera-
tive repair had a postoperative mortality of 0.5% (n ¼ 3/
556) versus 7.5% for patients undergoing urgent repair
(n ¼ 8/106).
Major nonfatal adverse outcomes. In multivariate analy-
sis, patients at least 70 years old had a 67% increase (OR,
1.67; 95%CI, 1.1–2.7) in the odds of major nonfatal adverse
outcomes relative to those younger than 70 years. Those
with age-adjusted CCI scores of at least 3 had a 66%
increase (OR, 1.66; 95% CI, 1.1–2.6) in odds of major non-
fatal adverse outcome. Odds of postoperative leak were
increased 3.8-fold (OR, 3.82; 95%CI, 1.2–12.7) for patients
with BMI of at least 35 kg/m2.
Postoperative LOS. Patients with CCI scores of at least 3
had a 2.7-fold increased odds of a long hospital stay (defined
as 5 days, OR, 2.7; 95% CI, 1.9–3.8) relative to patients
with a CCI score lower than 3. There was a trend toward in-
creased odds of a long hospital stay in the current era (OR,
1.4; 95% CI, 0.96–2.0; P ¼ .08) relative to the early era,
which disappeared after controlling for comorbidities (OR,
1.3 for LOS 5 days in current era; 95% CI, 0.86–1.8;
P ¼ .24).
Symptom Relief and Quality of Life
Recent symptom follow-up was available for 74% of
patients (n ¼ 492/662). Median time to follow-up was 30
months (IQR 17–56 months). There were 170 patients with-
out symptom follow-up (74 deceased and the remaining 96
declining or unavailable for follow-up). Symptom follow-
up, validated GERD-HRQoL, and SF-36 were more likely
to be missing if patients were at least 80 years old (P ¼
.02, P<.001, and P<.001, respectively) or had a CCI score
of 3 or greater (P¼ .01, P¼ .01, and P¼ .001, respectively).
Early era of surgery was significantly associated with
missing GERD-HRQoL (P ¼ .001) and SF-36 (P ¼ .002)
measures.
Symptomatic relief after laparoscopic GPEH repair.
Overall, patients had significant relief of preoperative
complaints (Table 2). The proportions of patients reporting
dysphagia, heartburn, regurgitation, chest or abdominal
pain, shortness of breath, and aspiration were significantly
reduced at current follow-up relative to preoperative levels.
The proportion of patients reporting postprandial bloating,
however, was unchanged. Of patients reporting postprandial
bloating before the operation, 33% had persistent symptoms
(n ¼ 47/144). In addition, 29% of patients without preoper-
ative bloating (n ¼ 97/337) reported this symptom at most
recent follow-up.
Symptoms and association with radiographic recur-
rence. There were no differences in rates of symptoms
between patients with radiographically documented recur-398 The Journal of Thoracic and Cardiovascular Surgrence and those without radiographic recurrence. Radio-
graphic recurrence was not associated with increased odds
of recurrent symptoms (Table 3).
Patient satisfaction, GERD-HRQoL, and SF-36. GERD-
HRQoL questionnaires were completed by 489 of 662
patients (74%) at a median of 30 months from initial oper-
ation (IQR, 17–56 months). According to the GERD-
HRQoL satisfaction scale, patient satisfaction with surgery
and current symptoms was high (Table 4). Radiographic
recurrence did not have a significant impact on patient-
reported satisfaction (P ¼ .79) or patient-reported reflux-
related quality of life and did not necessitate reoperation in
most cases.
Finally, overall patient satisfaction was assessed with the
SF-36 instrument. A complete SF-36 was available for anal-
ysis in 476 of 662 cases at a median time from initial oper-
ation of 30 months (IQR, 17–56 months; Table 4).
Radiographic and Symptomatic Recurrence and
Need for Reoperation
Long-term radiographic recurrence and need for reop-
eration. Postoperative barium esophagograms were avail-
able for 92% of patients (n ¼ 607/662). For 67% of
patients (n ¼ 445/662), the esophagogram was obtained 3
months or longer after operation. Lack of a barium esopha-
gogram obtained 3 months or longer after operation was sig-
nificantly associated with age of at least 80 years at time of
operation (P¼ .04) but not with sex, CCI, BMI, or era of op-
eration. Median time to most recent esophagogram was 25
months (IQR, 12–46 months). Recurrent hiatal hernia was
identified in 70 of 445 patients (15.7%) at a median of 22
months (IQR, 11–39 months). Most radiographic recur-
rences were small (between 11% and 20% reherniation of
the stomach or wrap). Radiographic recurrence and signifi-
cant symptoms leading to a decision to reoperate were pres-
ent in 3.2% of patients (n ¼ 21/662) at a median follow-up
of 25 months (IQR, 17–43 months), with the decision to reo-
perate driven primarily by the degree of clinical symptoms.
Risk factors for radiographic recurrence and need for
reoperation for recurrence. Age younger than 70 at initial
operation was associated with significantly increased odds of
radiographic recurrence. Age younger than 70 at initial oper-
ation, BMI of at least 35 kg/m2, and mesh cruroplasty at ini-
tial operation were associated with an increased odds of need
for reoperation in crude and adjusted analyses (Table 5).
DISCUSSION
With this single-institution, decade-long series of 662
patients, we have demonstrated that laparoscopic GPEH re-
pair is feasible, is safe, and provides excellent patient satis-
faction and symptom resolution despite an increase in
patient comorbid conditions during the study period. Lapa-
roscopic repair of GPEH was successfully accomplished in
98.5% of cases, with a postoperative mortality of 1.7%ery c February 2010
TABLE 2. Paired analysis of the relationship between preoperative and current symptoms
Symptom present preoperatively?
Current symptom Yes No Difference in proportion* Odds ratioy P valuez
Dysphagia
Yes 76 55 0.20 (0.25 to0.14) 0.34 (0.25–0.47) <.0001
No 160 246
Heartburn
Yes 100 27 0.44 (0.49 to0.39) 0.1 (0.07–0.15) <.0001
No 261 138
Regurgitation
Yes 28 20 0.48 (0.53 to0.43) 0.08 (0.05–0.12) <.0001
No 261 193
Chest or abdominal pain
Yes 34 30 0.42 (0.47 to0.36) 0.13 (0.09–0.19) <.0001
No 228 183
Postprandial bloating
Yes 47 97 0.02 (0.08 to 0.04) 0.92 (0.69–1.2) .53
No 106 240
Aspiration
Yes 2 12 0.09 (0.12 to0.05) 0.24 (0.11–0.45) <.0001
No 51 387
Shortness of breath
Yes 31 29 0.29 (0.34 to0.23) 0.18 (0.12–0.27) <.0001
No 163 243
Proton pump inhibitors
Yes 161 31 0.41 (0.46 to0.36) 0.12 (0.08–0.18) <.0001
No 249 89
*Difference in proportion is given with 95% confidence interval in parentheses. yOdds ratio represents likelihood of having a symptom currently if it was present preoperatively;
95% confidence interval is given in parentheses. zMcNemar c2 test for analysis of paired variables.
Luketich et al General Thoracic Surgery
G
T
Sand major morbidity rate of 19%. Thromboembolic com-
plications were a significant source of postoperative mor-
bidity, despite routine use of antithrombotic compression
stockings and subcutaneous heparin. Patient factors that
were predictive of increased risk of postoperative death
and significant major adverse events were age of at least
70 years, BMI of at least 35 kg/m2, CCI score of at least
3, and urgent operation. Symptom relief after laparoscopic
repair was excellent, with 89% of patients expressing sat-
isfaction with the surgical result at 30 months’ median clin-
ical follow-up. Importantly, patients with a limited
radiographic recurrence were as satisfied with surgery as
those with no radiographic recurrence and reported similar
GERD-HRQoL outcomes.
When the current era of operation (July 1, 2003–June 30,
2008) was compared with the early era (January 1, 1997–
June 30, 2003), patients in the current era were 50%
more likely to have significant age-adjusted comorbidities
and 60% more likely to have an underlying pulmonary dis-
ease. Despite this, the risk of adverse outcome in the current
era was the same as in the early era. Operative time and
need for reoperation in the immediate postoperative period
were significantly less in the current era, reflecting the expe-
rience of the surgical team, ongoing efforts to refine the
operative approach, and improvements in perioperative
patient care.The Journal of Thoracic and CaThe only patient characteristic that was associated with
risks of radiographic recurrence and reoperation on multi-
variate analysis was age younger than 70 years at initial op-
eration. Such an association with younger age has not been
previously described, but a possible hypothesis for this
observation is that younger patients are healthier and more
active, thereby exerting greater stress on the hiatal repair.
This may be a subpopulation in which routine crural rein-
forcement with mesh can lead to improved long-term dura-
bility of the repair. Further studies are needed to confirm this
association and test this hypothesis.
Laparoscopic Versus Open Repair
The operative outcomes, long-term symptomatic relief,
and freedom from radiographic recurrence after laparo-
scopic repair of GPEH reported here are similar to the out-
comes for open repair reported in the literature. Our
operative mortality of 1.7% compares quite well with mor-
talities of 0% to 3.7% that have been reported.10-12 Interest-
ingly, we found that the operative mortality for elective
repair was significantly lower than that for urgent repair
(0.5% vs 7.5%), which contradicts recent studies13 suggest-
ing that mortalities for elective and emergency repairs are
not substantially different. In our series, elective repairs in
the hands of experienced surgeons had significantly better
outcomes than did urgent repairs by the same surgeons.rdiovascular Surgery c Volume 139, Number 2 399
TABLE 3. Comparison of current symptoms between patients with
recurrent hernia according to barium esophagography and those
without recurrent hernia
Radiographic
recurrence?*
Current symptom Yes No P valuey
Crude odds
ratioz
Dysphagia (n ¼ 380)
Yes (n ¼ 94, 25%) 15 79 .13 1.75 (0.89–3.5)
No (n ¼ 286, 75%) 28 258
Heartburn (n ¼ 373)
Yes (n ¼ 101, 27%) 11 90 >.999 0.92 (0.44–1.9)
No (n ¼ 272, 73%) 32 240
Regurgitation (n ¼ 350)
Yes (n ¼ 36, 10%) 6 30 .28 1.65 (0.64–4.3)
No (n ¼ 314, 90%) 34 280
Chest or abdominal
pain (n ¼ 330)
Yes (n ¼ 46, 14%) 7 39 .31 1.58 (0.65–3.9)
No (n ¼ 284, 86%) 29 255
Postprandial bloating
(n ¼ 408)
Yes (n ¼ 122, 30%) 16 106 .50 1.24 (0.65–2.67)
No (n ¼ 286, 70%) 31 255
Aspiration (n ¼ 318)
Yes (n ¼ 11, 4%) 1 10 1.00 0.92 (0.11–7.5)
No (n ¼ 307, 96%) 30 277
Shortness of breath (n ¼ 326)
Yes (n ¼ 48, 15%) 7 41 .31 1.59 (0.65–3.9)
No (n ¼ 278, 85%) 27 251
Proton pump inhibitors (n ¼ 369)
Yes (n ¼ 145, 39%) 16 129 1.00 0.99 (0.51–1.9)
No (n ¼ 224, 61%) 25 199
*Analysis includes only those patients with barium esophagogram at least 3 months
after initial operation and current symptoms. If patients required reoperation (including
for recurrent hernia, treatment of obesity, or esophageal cancer), symptom follow-up
was censored to the most recent symptoms before reoperation. yFisher’s Exact Test for
differences in symptoms between patients with and without radiographic recurrence.
zFor odds ratio, 95% confidence interval is given in parentheses.
TABLE 4. Analysis of the impact of radiographic recurrence on
gastroesophageal reflux disease–related and overall patient health
status at current clinical follow-up
Radiographic recurrence*
All
patients Yes No
P
value
Satisfied with surgery and current symptoms
n ¼ 493 n ¼ 41 n ¼ 314
Yes 440 (89%) 37 (90%) 284 (90%) .79y
No 53 (11%) 4 (10%) 30 (10%)
Gastroesophageal Reflux Disease Health Related Quality of Lifez
n ¼ 489 n ¼ 41 n ¼ 312
Median and IQR 1 (0-4) 1 (0-4) 2 (0-6) .33x
Excellent to good 438 (90%) 36 (88%) 279 (89%) .79y
Fair to poor 51 (10%) 5 (12%) 33 (11%)
Short-form 36 Health Survey (median and IQR)
n ¼ 476 n ¼ 40 n ¼ 304
Physical Component
Summary
51 (40-57) 54 (48-57) 51 (40-57) .12x
Mental Component
Summary
53 (47-56) 53 (49-56) 53 (49-56) 62x
IQR, Interquartile range. *Includes only patients with current barium esophagogram
and Short-form 36 Health Survey score. Results for patients requiring reoperation
were censored at the date of reoperation. yTwo-sample Wilcoxon rank-sum (Mann-
Whitney) test zScale as follows: excellent (score 0–5), good (score 6–10), fair (score
11–15), poor (score>15). xFisher’s Exact Test for independence.
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ciation more clearly.
Our radiographic recurrence and symptom outcomes also
compare favorably with the outcomes reported for open
repair and contrast with the high rates of radiographic recur-
rence published in some series of laparoscopic repair.7,10,14-16
Hashemi and colleagues10 in 2000 were among the first to
publish a high rate of radiographic recurrence for patients un-
dergoing laparoscopic repair (42% radiographic recurrence
rate in 27 patients, median time to barium esophagogram
17 months). This sharply contrasted with the 15% radio-
graphic recurrence rate in the open group (median time to
barium esophagogram 35 months). Symptomatic relief was
also worse in their laparoscopic group; 77% of patients re-
ported a good to excellent outcome versus 88% in their
open group. These results emphasize the need for surgeons400 The Journal of Thoracic and Cardiovascular Surgto assess their ongoing clinical outcomes and strive for supe-
rior outcomes with the surgical approach that works best for
their group. In our center, extensive minimally invasive sur-
gical experience and good to excellent results in close to 90%
of our patients undergoing laparoscopic repair of GPEH has
led to our adoption of this approach in preference to the open
approach.
Ongoing Debate Regarding Mesh Cruroplasty and
Esophageal Lengthening
The roles of esophageal lengthening and mesh cruroplasty
in repair of GPEH continue to be debated among surgeons,
and a clear answer does not exist.7,17-21 Hiatal herniation is
associated with two distinct processes: axial tension caused
by proximal migration of the gastroesophageal junction in
the setting of acquired short esophagus and radial tension
exerted on the hiatal orifice as the hernia enlarges.22 The
goal of esophageal lengthening is to eliminate the axial ten-
sion exerted on the hiatus by creating an adequate length of
intra-abdominal neoesophagus. The goal of mesh cruro-
plasty is to strengthen the ability of the hiatus to resist radial
tension created by the pressure differential between the ab-
domen and thorax. As such, use of either esophageal length-
ening or mesh cruroplasty is an intraoperative decision that
should be made after optimal surgical mobilization of the
esophagus and diaphragm. The surgeon then determines
the best repair for the patient. The optimal repair may requireery c February 2010
TABLE 5. Analysis of preoperative risk factors and operative techniques and the risk of reoperation and radiographic recurrence at any time after
operation
Radiographic recurrence (n ¼ 445)* Reoperation for recurrent hernia/symptoms
No. Crude ORy P value No. Crude ORy P value
Overallz 70/445 (15.7%) 21/662 (3.2%)
Age at initial operation
<70 y 44/235 (19%) Referent .07 16/326 (4.9%) Referent .01
70 y 26/210 (12%) 0.61 (0.36–1.04) 5/336 (1.5%) 0.29 (0.11–0.81)
Age-adjusted Charlson
comorbidity index
<3 (n ¼ 334) 42/239 (18%) Referent .25 12/334 (3.6%) Referent .53
3 (n ¼ 328) 28/206 (14%) 0.74 (0.44–1.24) 9/326 (2.7%) 0.76 (0.3–1.8)
Body mass index
<35 kg/m2 50/351 (14%) Referent .09 15/528 (2.8%) Referent .07
35 kg/m2 15/67 (22%) 1.74 (0.91–3.3) 6/92 (6.5%) 2.4 (0.9–6.3)
Preoperative pulmonary disease
None (n ¼ 499) 51/337 (15%) Referent .54 13/499 (2.6%) Referent .15
Present (n ¼ 163) 19/108 (18%) 1.2 (0.67–2.13) 8/163 (4.9%) 1.93 (0.78–4.75)
Preoperative hernia sizex
30%–49% 28/189 (15%) Referent .60jj 12/280 (4.3%) Referent .1
50%–74% 10/67 (15%) 1.0 (0.46–2.2) 4/87 (4.6%) 1.1 (0.3–3.4)
75%–99% 17/99 (17%) 1.2 (0.6–2.3) 2/148 (1.4%) 0.3 (0.1–1.4)
Complete intrathoracic stomach 15/90 (17%) 1.2 (0.58–2.3) 3/147 (2.0%) 0.5 (0.1–1.7)
Type of fundoplication{
Partial 16/100 (16%) Referent .89 6/135 (4.4%) Referent .37
Circumferential 52/337 (15%) 0.96 (0.52–1.77) 15/512 (2.9%) 0.65 (0.25–1.7)
Esophageal lengthening
None (n ¼ 212) 24/165 (15%) Referent .65 10/239 (4.2%) Referent .3
Collis gastroplasty (n ¼ 383) 44/272 (16%) 1.13 (0.66–1.94) 11/408 (2.7%) 0.63 (0.27–1.5)
Mesh cruroplasty
None (n ¼ 574) 58/387 (15%) Referent .27 13/574 (2.3%) Referent .0007
Mesh (n ¼ 88) 12/58 (21%) 1.48 (0.74–2.97) 8/88 (9.1%) 4.3 (1.7–10.8)
Operative time
<260 min 46/331 (14%) Referent .07 14/480 (2.9%) Referent .54
260 min 24/114 (21%) 1.65 (0.95–2.86) 7/182 (3.9%) 1.3 (0.5–3.4)
*Analysis includes only those patients with barium esophagogram yFor odds ratio, 95% confidence interval is given in parentheses. zAnalysis was also performed for preoperative
pulmonary function testing, history of peptic ulcer disease or diabetes, postoperative complications (leak, pneumonia, acute renal failure, perioperative hernia recurrence, any need
for reoperation in the perioperative period), and no association with risk for reoperation and radiographic recurrence was identified. xPercentage of stomach within the mediastinum
determined by barium esophagography, preoperative endoscopy, or intraoperative description. Complete intrathoracic stomach was defined as the entire stomach, including the
antrum, herniated into the mediastinum. jjP value for score test for trend of odds. {Two patients with recurrence did not receive a fundoplication at the initial operation (1 gastropexy
and 1 Roux-en-Y gastric bypass).
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not the other, or neither.
In our series, use of mesh cruroplasty in most cases was
not necessary in the opinion of the surgeon. We believe
that two factors are critical to the success of primary crural
reapproximation: (1) maintenance of the peritoneal lining
over the crura, and (2) complete division of all attachments
from the diaphragm to the stomach and spleen. This allows
free mobility of the left limb of the crus and facilitates reap-
proximation without tension. In our experience, we accom-
plished these ends most of the time, and mesh was only
required in 13% of cases when the overlying peritoneum
had been compromised, leading to exposed muscle fibers
of poor integrity, or the hiatal opening could not be closed
without undue tension. The finding in our series that meshThe Journal of Thoracic and Cacruroplasty was associated with significantly increased
odds of reoperation for recurrence with time and was not
protective against radiographic recurrence reflects the fact
that we use mesh only when the crural closure is compro-
mised. Similarly, this finding may also indicate that the
type of mesh and the technical aspects of the cruroplasty
are still in evolution and that the ideal approach has not
been determined.
Conversely, Collis gastroplasty for esophageal lengthen-
ing was used in 63% of patients in this series. Most of our
patients had type III paraesophageal hernia. Restoring ade-
quate length to the intra-abdominal esophagus returns the
gastroesophageal junction to the abdomen and releases the
axial tension created by the shortened esophagus, thereby
minimizing the axial forces exerted on the hiatal repair.rdiovascular Surgery c Volume 139, Number 2 401
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with time in our series, in our opinion, this is because of
the increased experience and success of extended mediasti-
nal mobilization. For some patients with mild to moderate
shortening, extended mobilization may obviate the need
for an esophageal lengthening procedure or at least may limit
the length of the Collis gastroplasty to a shorter segment.
This is clearly an important component of the repair, and
every effort should be made to strive for adequate esopha-
geal length with laparoscopic esophageal mobilization to
the maximal degree possible before determining whether
a Collis gastroplasty is indicated.
Study Limitations
This study has several strengths and limitations. Long-
term follow-up of this patient population can be difficult to
obtain because of the extremes of age and also the costs of
maintaining a clinical outcomes research team. We present
midterm validated patient-reported outcomes for 74% of pa-
tients at a median follow-up of 30 months. Radiographic fol-
low-up at least 3 months after operation was available for
67% of patients at a median follow-up of 25 months.
Although these numbers are comparable to other se-
ries,10,14,15,23,24 a concerted effort has been made during
the past 2 years to improve our longitudinal care for these pa-
tients, and clinical pathways have been instituted at our cen-
ter to provide routine and standardized follow-up. Despite
these measures, serial time points were not available for
most patients, limiting assessment of the time course for
radiographic or symptom recurrence.
The degree of missing data for the outcomes measured in
this study is also a limitation of the study. When factors
associated with missing data were analyzed, we found that
patients who were 80 years or older at the time of operation,
those with significant comorbid illness, and those operated
on during the early era were more likely to be missing fol-
low-up symptom questionnaires and validated quality of
life studies. Octogenarians were also more likely to be miss-
ing a barium esophagogram obtained at least 3 months after
the operation. This degree of missing data introduces bias
into the analysis that must be taken into consideration. For
example, the percentage of patients reporting postoperative
dysphagia may be underestimated by the findings of this
study, because elderly patients are more likely to have dys-
phagia than are younger patients. It is also possible that the
increased rate of radiographic recurrence in younger patients
is reflective of the higher rate of availability of follow-up
barium esophagography in this group rather than a true
increased risk of radiographic recurrence.
Analysis of preoperative symptoms was also limited by
the fact that most of these data were derived from retrospec-
tive review of existing medical records. Although most
patients had clear prospective documentation of the presence
or absence of symptoms such as reflux, regurgitation,402 The Journal of Thoracic and Cardiovascular Surgdysphagia, and shortness of breath, other symptoms, such
as cough and hoarseness, were less well documented.
Such important postoperative symptoms as early satiety,
diarrhea, and excessive flatulence were rarely assessed
preoperatively. These symptoms can be the source of
long-term patient dissatisfaction and warrant further study.Summary
In the largest series to date, we found that laparoscopic
repair of GPEH is technically feasible, is associated with
good to excellent outcomes in close to 90% of patients,
and carries low morbidity and mortality in the hands of ex-
perienced surgeons. Patients who are obese, who are older,
and who have a greater burden of comorbid illness are at
higher risk for adverse postoperative outcomes, but most
of these patients can still undergo laparoscopic repair with
good results. Decisions regarding esophageal lengthening
and mesh cruroplasty are best made at the time of operation
on the basis of the specific anatomic considerations of the
individual patient. Laparoscopic repair of GPEH provides
excellent patient satisfaction and symptom resolution, with
reoperation rates that are comparable to those of the best
open series.10,25References
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Dr Toni Lerut (Leuven, Belgium). It is a privilege for me to dis-
cuss this excellent and important presentation reporting an in-depth
study on the results of what is now by far the largest series on re-
pairs of GPEH. The conclusion is that laparoscopic repair provides
excellent patient satisfaction and symptom resolution, with reoper-
ation rates comparable to those of the best open series. Despite your
obvious enthusiasm, Dr Luketich, I do have some concerns and
questions.
This surgery remains to be considered as a complex and major
surgery, with duration of intervention, major complication rates,
and mortality figures equaling those now obtained for esophagec-
tomy in centers of excellence, in fact 1.4% for your own center.
The overall reintervention rate, including reoperation for recur-
rence, was 8% in this series, whereas recurrence remains as high
as 15%. Although patient satisfaction reached 90%, a detailed anal-
ysis of your data indicates that postoperative symptoms such as
dysphagia, heartburn, and bloating are recurring in about 1 in 4
cases, and the need for proton pump inhibitor continuation is as
high as 40%. So to me it appears that we are not yet there. I have
3 questions.
First, your 30-day mortality was 1.7%, but overall 85 patients
died during follow-up. Because half of the patients in your series
were older than 70 years or had a CCI score of 3 or more, what
were the 6-month and 1-year mortalities, which in fact reflect
much more better the true postoperative mortality?
Second, Stylopoulos and Rattner in 2002, with a Markov Monte
Carlo decision analytic model, calculated that for the many patients
with minor symptoms, such as heartburn, bloating, and so on, a pol-
icy of watchful waiting entails a lifetime risk of development of
acute symptoms requiring surgery estimated at 1.1% per year,
with mortality related to emergency surgery of 5.4%. So they cal-The Journal of Thoracic and Caculated an overall lifetime risk of dying of paraesophageal hernia
in a patient managed by watchful waiting to be 1%, which is less
than the 30-day mortality in your series. Given these data, and
given the high comorbidity in your population, your median age
of 70 years, the substantial postoperative complications and read-
mission rate, and the 8% mortality rate among patients older than
80 years, what according to your experience are now the guidelines
for this subset of patients?
Dr Luketich. Could you just summarize that second question? I
didn’t quite hear the question at the end.
Dr Lerut.Given Rattner’s data and the high comorbidity in your
population, your median age of 70 years, your high readmission
and complication rate, and the high postoperative mortality in pa-
tients older than 80 years, what are your guidelines for this subset
of patients?
Dr Luketich. Guidelines for entry for elective repair?
Dr Lerut. Exactly.
Dr Luketich. I see.
Dr Lerut. Finally, the recurrence rate was 15%. Could you tell us
whether in this subset of patients you performed with time subse-
quent barium esophagography? If so, did this show further progres-
sion of the size of such intrathoracic migration, particularly in the
group of younger patients who seem to bemore at risk for recurrence
simply by virtue of surviving longer than the elderly group?What is
the scheme, the algorithm, for follow-up in those cases?
Dr Luketich. Thank you, Dr Lerut. To the first question, the
mortalities at 6 months and 1 year, I can’t give you those data.
We looked primarily at 30-day mortality. Certainly in looking
at this group of elderly patients, there are obviously natural deaths
occurring in significant numbers among these patients with time.
What we did find was that if the CCI score was low and the pa-
tient was younger than 70 years, or even older than 70 years with
a low CCI score, the 30-day mortality was nil. I hope that
answers that question. We do have the data to look more closely
at exactly which patients died of at 6 months and 1 year, but it
was clear that these deaths did not appear to be related to the
operation.
I’ll answer the last question next, because I am not sure I under-
stand or can answer the second question. Looking at those small ra-
diographic recurrences, no doubt they are a significant concern. If
we try and repair a hiatal hernia, an incisional hernia, or a groin her-
nia and have any type of hernia recurrence, we are always con-
cerned that it is going to lead to a larger recurrence, then
potential symptoms, and then reoperation. I can tell you that
when we looked at that first subset of patients back in 2000,
when Andrew Pierre presented those data, we had a reoperative
rate of around 2%. Those patients have a follow-up now of 77
months, with a reoperation rate up to 4%. I think that may be where
the rate is peaking. That is what it looks like to us; most of the re-
currences that require reoperation are within 2 to 3 years. Once we
get beyond that, we seem to see very few. There will be some, I am
certain, and we have seen a few, but not many. And even in this ar-
ticle, when you look at the early data compared to the late data, it
does appear that there is some stability of that radiographic recur-
rence.
In looking back at the laparoscopic randomized trial that was
presented at the American Surgical Society meeting a couple of
years ago, those were 6-month data showing 9% radiographicrdiovascular Surgery c Volume 139, Number 2 403
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data have not been presented on that, but it will be interesting to see
how many of those recurrences become symptomatic and how
many require reoperation with mesh. We have tried to present
that, most recently at the Digestive Disease Week, with our 77-
month follow-up, as I mentioned.
In terms of establishing better guidelines for elective repair and
looking at the likelihood of significant symptoms and whether these
patients should undergo surgery or maybe would best be consid-
ered for medical treatment, a variety of indexes have been proposed
to address this question. In our clinics, what we are seeing is primar-
ily referral for symptoms, for specific problems, whether anemia,
dysphagia, pain, heartburn, or whatever. Although there is no doubt
that some of those patients still have symptoms after the surgery,
what isn’t known or is difficult to assess is the level of the symp-
toms. That is, results are less meaningful if you look merely at pres-
ence or absence of dysphagia, versus an index of occasional
problems with hard solids. A significant number of the patients
fall into that category; they are eating a regular diet but have occa-
sional dysphagia with hard solids. I think part of that is related to the404 The Journal of Thoracic and Cardiovascular SurgCollis gastroplasty. It does lead to a small segment of relatively
amotile neoesophagus, and that can dilate with time. No doubt,
the Collis gastroplasty carries some significant limitations. In lieu
of getting that tension-free segment of intra-abdominal esophagus,
however, it is probably the best approach to that group of patients
short of further esophageal mobilization. We have not really
changed our guidelines, but we are trying now to evaluate those
symptoms more closely, because it is clear that some of them are
present. All decrease significantly with time. And the one thing
that is important to look at is the final analysis of surgical satisfac-
tion and the final analysis of the GERD-HRQoL score being 90%
improved.
So we don’t have the answer to some of those questions. I can
tell you that we are looking at the issue and trying to study it
more carefully. We have established detailed questionnaires, and
it takes significant amounts of time and money to follow each of
these questions carefully with time and try to assign a score, rather
than a yes or no. Most of these patients do seem very satisfied, very
happy, even when they come to the postoperative clinics with some
of these symptoms present.ery c February 2010
APPENDIX E1. Details of Surgical Technique
In 2003, the approach switched from a hand-over-hand
technique1,2 to an approach that begins with complete reduc-
tion of the hernia sac. The hernia sac is grasped just inside the
diaphragmatic crura at the 12 o’clock position, and the lining
of the sac is everted and incised with ultrasonic dissection,
allowing access to the areolar attachments of the hernia sac
to mediastinal structures. Dissection in this plane is associ-
ated with little blood loss and easy visualization of the bilat-
eral pleura, esophagus, and vagus nerves and reduces the
entire hernia sac into the abdomen, thereby returning the
stomach to its anatomic position.
As the reduction is completed, the sac is incised just inside
the crura, with care taken to preserve the crural peritoneal lin-
ing. Esophageal mobilization within the mediastinum is rou-
tinely performed to at least the level of the inferior
pulmonary veins. Anterior and posterior vagus nerves are
identified and preserved. Short gastric vessels are divided
and the gastric fat pad mobilized to allow visualization of
the gastroesophageal junction, and the intra-abdominal loca-
tion of the gastroesophageal junction in a neutral resting po-
sition in the abdomen is assessed. Dissection continues until
a minimum of 2 cm of tension-free intra-abdominal esopha-
gus is present. If further mobilization fails to produce a ten-
sion-free segment of intra-abdominal esophagus, we perform
an esophageal lengthening procedure. Initially, we used the
end-to-end anastomosis technique.1 As we gained experi-
ence, we converted to doing stapled wedge gastroplasty, as
described by Whitson and colleagues,8 because of the ease
of performing the technical steps and the greater reproduc-
ibility in resident teaching than with the end-to-end anasto-
mosis technique. An antireflux procedure (a floppy Nissen
fundoplication in most cases) is routinely performed. The
crura are then reapproximated without tension with nonab-
sorbable 0 suture. If the crura are denuded of overlying peri-
toneum, are unable to hold sutures because of significant
attenuation, or cannot be reapproximated without tension,
mesh reinforcement with bioprosthetic mesh is performed.
In some cases of very poor esophageal motility, extremes
of age, signs of clinical instability (such as intraoperative
desaturations or blood pressure instability despite the usual
corrective measures), or extreme technical problems, the sur-
geon may elect intraoperatively to perform an extended gas-
tropexy. When this is chosen, complete hernia sac dissection
and crural reapproximation are still performed. Gastropexy is
performed from the greater curve of the stomach to the left
crus and continued along the anterior abdominal wall toward
the umbilicus. A gastrostomy tube is placed along this gas-
tropexy line to secure further the intra-abdominal location
of the stomach.
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